These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36293505)

  • 1. Using Computational Drug-Gene Analysis to Identify Novel Therapeutic Candidates for Retinal Neuroprotection.
    Xie E; Nadeem U; Xie B; D'Souza M; Sulakhe D; Skondra D
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Age-Related Macular Degeneration.
    Nadeem U; Xie B; Xie EF; D'Souza M; Dao D; Sulakhe D; Skondra D
    Transl Vis Sci Technol; 2022 Aug; 11(8):10. PubMed ID: 35972434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal neuroprotection: current strategies and future directions.
    Wubben TJ; Zacks DN; Besirli CG
    Curr Opin Ophthalmol; 2019 May; 30(3):199-205. PubMed ID: 30844942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.
    Rapino C; Tortolani D; Scipioni L; Maccarrone M
    Curr Neuropharmacol; 2018; 16(7):959-970. PubMed ID: 28738764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal Neuroprotection: Overcoming the Translational Roadblocks.
    Wubben TJ; Besirli CG; Johnson MW; Zacks DN
    Am J Ophthalmol; 2018 Aug; 192():xv-xxii. PubMed ID: 29702074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
    Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
    Elife; 2021 Jun; 10():. PubMed ID: 34184634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms.
    Xu Z; Lei Y; Qin H; Zhang S; Li P; Yao K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comprehensive strategy for retinal neuroprotection. Challenging the clinical application].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):165-98; discussion 199. PubMed ID: 22568101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection.
    Thiersch M; Raffelsberger W; Frigg R; Samardzija M; Wenzel A; Poch O; Grimm C
    BMC Genomics; 2008 Feb; 9():73. PubMed ID: 18261226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective strategies for retinal disease.
    Pardue MT; Allen RS
    Prog Retin Eye Res; 2018 Jul; 65():50-76. PubMed ID: 29481975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.
    Payne AJ; Kaja S; Naumchuk Y; Kunjukunju N; Koulen P
    Int J Mol Sci; 2014 Jan; 15(2):1865-86. PubMed ID: 24473138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-analgesic effects of opioids: neuroprotection in the retina.
    Husain S; Abdul Y; Potter DE
    Curr Pharm Des; 2012; 18(37):6101-8. PubMed ID: 22747547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome.
    Johnson TV; DeKorver NW; Levasseur VA; Osborne A; Tassoni A; Lorber B; Heller JP; Villasmil R; Bull ND; Martin KR; Tomarev SI
    Brain; 2014 Feb; 137(Pt 2):503-19. PubMed ID: 24176979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa.
    Brown C; Agosta P; McKee C; Walker K; Mazzella M; Alamri A; Svinarich D; Chaudhry GR
    Stem Cell Res Ther; 2022 Apr; 13(1):148. PubMed ID: 35395806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Excitatory Amino Acid Transmission in the Retina: Studies on Neuroprotection.
    Opere CA; Heruye S; Njie-Mbye YF; Ohia SE; Sharif NA
    J Ocul Pharmacol Ther; 2018; 34(1-2):107-118. PubMed ID: 29267132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma.
    Kimura A; Guo X; Noro T; Harada C; Tanaka K; Namekata K; Harada T
    Neurosci Lett; 2015 Feb; 588():108-13. PubMed ID: 25555796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist.
    Coyner AS; Ryals RC; Ku CA; Fischer CM; Patel RC; Datta S; Yang P; Wen Y; Hen R; Pennesi ME
    PLoS One; 2016; 11(7):e0159776. PubMed ID: 27447833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in glaucoma.
    Vishwaraj CR; Kavitha S; Venkatesh R; Shukla AG; Chandran P; Tripathi S
    Indian J Ophthalmol; 2022 Feb; 70(2):380-385. PubMed ID: 35086201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection for glaucoma: Requirements for clinical translation.
    Levin LA; Crowe ME; Quigley HA;
    Exp Eye Res; 2017 Apr; 157():34-37. PubMed ID: 27955999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.